Neurohormonal regulation of pancreatic exocrine function in rats without gene expression of the cholecystokinin-A receptor.
Otsuka Long-Evans Tokushima Fatty (OLETF) rats revealed no or reduced expression of the cholecystokinin (CCK)-A receptor gene in the pancreas and that the pancreas of this strain of rats did not respond to CCK stimulation. We examined whether the pancreatic responses to hormonal and neural stimulation except for CCK in OLETF rats were maintained. The pancreatic responses of conscious OLETF rats to various stimuli were examined in vivo and compared with those of control (Long-Evans Tokushima; LETO) rats. Moreover, the levels of expression of CCK-A and -B receptor genes in the small intestine were examined. Pancreatic responses to intravenous injection of secretin and acetylcholine and to intracerebroventricular administration of thyrotropin-releasing hormone were comparable in OLETF and LETO rats. However, responses to intravenous injection of neuromedin C, to intraduodenal injection of capsaicin, and to intragastric injection of a liquid meal were impaired in OLETF rats. CCK-A receptor mRNA was not expressed in the small intestine of OLETF rats but was in LETO rats. The pancreatic responses to various stimuli in OLETF rats were well conserved except for the involvement of CCK-A receptor function. OLETF rats are confirmed as a new experimental model deficient in CCK-A receptor gene expression and represent a useful tool for studying the physiological role of these in vivo.
Miyasaka
K
K
Department of Clinical Physiology, Tokyo Metropolitan Institute of Gerontology, Japan.
Masuda
M
M
Kawanami
T
T
Funakoshi
A
A
D000109:Acetylcholine / Q000031:analogs & derivatives / Q000494:pharmacology; D000704:Analysis of Variance; D000818:Animals; D001483:Base Sequence; D001839:Bombesin / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology; D004386:Duodenum; D005786:Gene Expression Regulation / Q000502:physiology*; D007267:Injections; D008297:Male; D008969:Molecular Sequence Data; D009490:Neurosecretory Systems / Q000502:physiology*; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D010446:Peptide Fragments / Q000494:pharmacology; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000235:genetics*; D012633:Secretin / Q000494:pharmacology; D012636:Secretory Rate / Q000187:drug effects; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D010446:Peptide Fragments; D012333:RNA, Messenger; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; D012633:Secretin; D013973:Thyrotropin-Releasing Hormone; C040794:neuromedin C; D000109:Acetylcholine; D001839:Bombesin; D002211:Capsaicin